LAUNCH DIAGNOSTICS LIMITED
Get an alert when LAUNCH DIAGNOSTICS LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-10-25 (in 5mo)
Last made up 2025-10-11
Watchouts
None on the register
Cash
£3M
+34.5% vs 2023
Net assets
£7M
-29.3% vs 2023
Employees
47
0% vs 2023
Profit before tax
£627K
+99.6% vs 2023
Net assets
2-year trend · vs Health Care median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | £13,523,805 | £14,431,518 | |
| Operating profit | £218,797 | £468,053 | |
| Profit before tax | £313,923 | £626,686 | |
| Net profit | £347,988 | £708,878 | |
| Cash | £2,134,036 | £2,871,107 | |
| Total assets less current liabilities | £10,207,314 | £7,344,322 | |
| Net assets | £10,116,767 | £7,151,953 | |
| Equity | £10,116,767 | £7,151,953 | |
| Average employees | 47 | 47 | |
| Wages | £2,607,982 | £2,753,196 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating margin | 1.6% | 3.2% | |
| Net margin | 2.6% | 4.9% | |
| Return on capital employed | 2.1% | 6.4% | |
| Current ratio | 5.57x | 3.45x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- BDO LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“At the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The Directors have assessed the continued impact of challenging macro-economic factors on the business, preparing budgets and cash flow forecasts to determine its ability to meet debts as and when they fall due. In preparing these forecasts, the Directors have considered the current and future economic conditions that are expected to prevail over the period. The forecasts also include assumptions regarding the timing of expected cashflows in the future. Based on the analysis performed management concluded that the company has adequate financial resources to continue operating as a going concern for a period of at least 12 months from the date of approval of these financial statements, the directors of Launch Diagnostics Limited therefore consider it appropriate to prepare the accounts on a going concern basıs”
Significant events
- “On 24 March 2025 the shareholders completed the sale of the entire share capital of the company to Duomed Belgium NV, a subsidiary of Palex Healthcare Group S LU”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
2 active · 12 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| JONES, Ian Antony | Director | 2025-04-28 | Jul 1971 | British |
| ODEZUGO, Chibuike | Director | 2025-11-20 | Feb 1986 | British |
Show 12 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| GARDINER, Tony Peter | Secretary | 2022-10-21 | 2024-08-29 |
| TWYCROSS, John | Secretary | — | 2010-10-30 |
| TWYCROSS, Margot | Secretary | 2010-10-30 | 2011-01-10 |
| BLANDY SERVICES LIMITED | Corporate Secretary | 2011-01-10 | 2022-10-21 |
| COUGHLIN, Christina, Dr | Director | 2024-04-30 | 2025-03-24 |
| GARDINER, Tony Peter | Director | 2022-10-21 | 2024-08-29 |
| HOFFMANN, Frédéric | Director | 2025-03-24 | 2025-11-20 |
| HUTCHINSON, Michael | Director | — | 2010-09-10 |
| MCGURK, Anne | Director | 2025-04-28 | 2025-11-20 |
| SMITH, David Alastair Maclaughlin, Dr | Director | 2022-10-21 | 2024-04-30 |
| TWYCROSS, John | Director | 2010-10-30 | 2022-10-21 |
| TWYCROSS, John | Director | — | 2010-10-30 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Launch Diagnostics (Holdings) Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-13 | Active |
Filing timeline
Last 20 of 144 total filings
Material constitutional events — rename, articles re-file, resolution
- 2025-04-02 RESOLUTIONS Resolution
- 2025-04-02 MA Memorandum articles
- 2025-01-03 RESOLUTIONS Resolution
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-02-23 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2026-01-06 | AA | accounts | Accounts with accounts type full | |
| 2025-11-21 | AP01 | officers | Appoint person director company with name date | |
| 2025-11-21 | TM01 | officers | Termination director company with name termination date | |
| 2025-11-21 | TM01 | officers | Termination director company with name termination date | |
| 2025-10-14 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-04-29 | AP01 | officers | Appoint person director company with name date | |
| 2025-04-28 | AP01 | officers | Appoint person director company with name date | |
| 2025-04-28 | AD01 | address | Change registered office address company with date old address new address | |
| 2025-04-02 | RESOLUTIONS | resolution | Resolution | |
| 2025-04-02 | MA | incorporation | Memorandum articles | |
| 2025-03-27 | AP01 | officers | Appoint person director company with name date | |
| 2025-03-27 | TM01 | officers | Termination director company with name termination date | |
| 2025-01-03 | RESOLUTIONS | resolution | Resolution | |
| 2024-10-11 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-10-07 | TM02 | officers | Termination secretary company with name termination date | |
| 2024-10-07 | TM01 | officers | Termination director company with name termination date | |
| 2024-06-13 | AA | accounts | Accounts with accounts type full | |
| 2024-05-29 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2024-05-02 | AP01 | officers | Appoint person director company with name date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 6
- Capital events
- 0
- Officers appointed
- 1
- Officers resigned
- 2
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
+6.7%
£13,523,805 £14,431,518
-
Cash
+34.5%
£2,134,036 £2,871,107
-
Net assets
-29.3%
£10,116,767 £7,151,953
-
Employees
0%
47 47
-
Operating profit
+113.9%
£218,797 £468,053
-
Profit before tax
+99.6%
£313,923 £626,686
-
Wages
+5.6%
£2,607,982 £2,753,196
Each % is (latest − prior) ÷ |prior| for the line item as filed. Periods don't have to be exactly 12 months apart — a long or short period (typical around incorporation or year-end changes) will distort the comparison. Lines a company doesn't report are omitted. About these numbers